intravenous human normal immunoglobulin 10%

· Kedrion S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intravenous human normal immunoglobulin 10%, covering 2026-04-27 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome [Phase 3]